A targeted approach to treating glioma

(Massachusetts Institute of Technology) Researchers from MIT, Brigham and Women's Hospital, and Massachusetts General Hospital have developed a new way to treat low-grade glioma. They devised a test that can rapidly check for the IDH mutation during brain surgery, and if the mutation is present, they can implant microparticles that gradually release an IDH-targeted drug over several days or weeks.
Source: EurekAlert! - Biology - Category: Biology Source Type: news